Arizona State Retirement System’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.4M Buy
37,928
+680
+2% +$222K 0.07% 240
2025
Q1
$10.1M Buy
37,248
+44
+0.1% +$11.9K 0.06% 258
2024
Q4
$8.75M Buy
37,204
+964
+3% +$227K 0.05% 300
2024
Q3
$9.97M Buy
36,240
+1,504
+4% +$414K 0.06% 275
2024
Q2
$8.44M Buy
34,736
+219
+0.6% +$53.2K 0.06% 286
2024
Q1
$5.16M Buy
34,517
+161
+0.5% +$24.1K 0.04% 398
2023
Q4
$6.58M Buy
34,356
+383
+1% +$73.3K 0.05% 326
2023
Q3
$6.02M Buy
33,973
+153
+0.5% +$27.1K 0.05% 323
2023
Q2
$6.42M Sell
33,820
-1,947
-5% -$370K 0.05% 327
2023
Q1
$7.16M Buy
35,767
+1,793
+5% +$359K 0.06% 300
2022
Q4
$8.07M Buy
33,974
+803
+2% +$191K 0.08% 255
2022
Q3
$6.64M Sell
33,171
-379
-1% -$75.9K 0.07% 274
2022
Q2
$4.89M Buy
33,550
+258
+0.8% +$37.6K 0.05% 360
2022
Q1
$5.44M Buy
33,292
+933
+3% +$152K 0.04% 378
2021
Q4
$5.49M Sell
32,359
-629
-2% -$107K 0.04% 394
2021
Q3
$6.23M Sell
32,988
-82
-0.2% -$15.5K 0.05% 341
2021
Q2
$5.61M Sell
33,070
-428
-1% -$72.6K 0.05% 382
2021
Q1
$4.73M Buy
33,498
+243
+0.7% +$34.3K 0.04% 423
2020
Q4
$4.32M Sell
33,255
-1,683
-5% -$219K 0.04% 414
2020
Q3
$5.09M Buy
34,938
+8,713
+33% +$1.27M 0.05% 328
2020
Q2
$3.88M Buy
26,225
+568
+2% +$84.1K 0.05% 316
2020
Q1
$2.79M Buy
+25,657
New +$2.79M 0.05% 393